Abbott Labs has continued to lag competitors like Boston Scientific and Stryker that are seen as more innovative and more likely to generate attractive revenue growth and margins. I think Abbott could ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Josh Jennings from TD Cowen maintained a Buy rating on the stock and ...

Abbott had a visible slowdown in top line and earnings margin starting in 2022 and continued in Q1's data. It is likely to have more persistent weakness in the bottom line in '23 and '24 to show up.

On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Organic sales growth for the underlying ...

Abbott Laboratories (NYSE: NYSE:ABT) has demonstrated resilience and growth potential in the healthcare sector, maintaining a strong financial profile despite facing various challenges. According to ...

Abbott's suite of electrophysiology products includes an ecosystem which combines the 3D mapping system, EnSite X, and a large portfolio of catheters and tools that operate on EnSite X. “The reason ...

Stereotaxis Inc (NYSE:STXS) shares are gaining after the company announced a global collaboration with Abbott Laboratories (NYSE:ABT) to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic ...

Revenues from the company's medical devices segment grew 12% in the quarter, fueled by double-digit gains in diabetes care, heart failure, electrophysiology, and rhythm management, with continuous ...

Abbott Laboratories (ABT +1.82%) is a diversified health care company that gives investors a great deal of stability. Between testing, nutritional products, pharmaceuticals, and medical devices, the ...

Abbott Laboratories is set to roll out its Volt PFA System in the U.S., following federal approval, and continue expanding the cardiology tool throughout Europe.

Two of Abbott’s electrophysiology products have recently received regulatory approval, one in Europe and the other in the United States. The company’s TactiFlex Ablation Catheter, Sensor Enabled, an ...